Jul 21, 2025 · We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.

Jul 16, 2025 · – After strategic review, Sarepta focuses pipeline on high-impact programs, prioritizing potentially best-in-class siRNA platform assets – Strategic restructuring includes …

Jul 22, 2025 · Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold a leadership position in Duchenne …

Read news and articles from Sarepta, a global biotechnology company developing potentially life-changing precision genetic medicine.

Learn about Sarepta's leadership and their goal to forever change the course of genetic disease.

Jul 19, 2025 · We are writing to clarify what happened, when we learned of this request, what Sarepta is doing about it, and most importantly, what it means for the community. First and …

Apr 8, 2025 · Sarepta’s industry leading pipeline is comprised of over 40 programs in various stages of development across 3 technologies, RNA, gene therapy and gene editing, and …

Sarepta is pursuing the development of precision genetic medicine at the forefront of biotechnology for rare diseases: gene therapy, RNA-targeted exon skipping, and gene editing.

Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.

The Investor Relations website contains information about Sarepta Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.